DW91170B / Dong Wha - LARVOL DELTA

DW91170B: A novel potent EZH1/2 dual inhibitor for adrenocortical carcinoma treatment (AACR 2025) - "In summary, the novel EZH1/2 inhibitor DW91170B exhibits anti-tumor efficacy in adrenocortical carcinoma. These effects appear to be mediated by alterations in cancer cell characteristics and the inhibition of cell survival."

Adrenal Cortex Carcinoma • Endocrine Cancer • Genito-urinary Cancer • Oncology • Solid Tumor • CYP11B1 • EZH2 • SMARCA4